Cargando…
Location First: Targeting Acute Myeloid Leukemia Within Its Niche
Despite extensive research and development of new treatments, acute myeloid leukemia (AML)-backbone therapy has remained essentially unchanged over the last decades and is frequently associated with poor outcomes. Eradicating the leukemic stem cells (LSCs) is the ultimate challenge in the treatment...
Autores principales: | Pievani, Alice, Biondi, Marta, Tomasoni, Chiara, Biondi, Andrea, Serafini, Marta |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7290711/ https://www.ncbi.nlm.nih.gov/pubmed/32443460 http://dx.doi.org/10.3390/jcm9051513 |
Ejemplares similares
-
Acute myeloid leukemia shapes the bone marrow stromal niche in vivo
por: Pievani, Alice, et al.
Publicado: (2020) -
A Question of Frame: The Role of the Bone Marrow Stromal Niche in Myeloid Malignancies
por: Tomasoni, Chiara, et al.
Publicado: (2023) -
Selective homing of CAR-CIK cells to the bone marrow niche enhances control of the acute myeloid leukemia burden
por: Biondi, Marta, et al.
Publicado: (2023) -
Engineering tandem CD33xCD146 CAR CIK (cytokine-induced killer) cells to target the acute myeloid leukemia niche
por: Alberti, Gaia, et al.
Publicado: (2023) -
Catch me if you can: how AML and its niche escape immunotherapy
por: Tettamanti, Sarah, et al.
Publicado: (2021)